Amygdala

Company Overview

Snapshot

Founded in September 2022 by Shani Sofer, Amygdala operated with 1–10 employees. The company raised $165K across one funding round from one investor. In October 2022, Amygdala secured pre-seed funding from Fusion VC.

Business overview

Amygdala is a Health Tech & Life Sciences company focused on revolutionizing mental health treatment through brain-computer interface technology. The company utilizes advanced deep learning algorithms to analyze and interpret brain activity, aiming to provide effective and personalized treatments for mental health conditions such as PTSD, depression, and anxiety. Amygdala operates in the Digital Healthcare sector, specifically within Medical Decision Support, and targets healthcare providers with its B2B business model.

Company Intelligence Q&A

What is Amygdala's primary focus?

Amygdala's mission is to revolutionize mental health treatment by leveraging cutting-edge brain-computer interface technology, focusing on conditions often resistant to traditional treatments like PTSD, depression, and anxiety.

When was Amygdala founded?

Amygdala was founded in September 2022.

Who is a key founder of Amygdala?

Shani Sofer is a Co-founder and CBO of Amygdala.

What is Amygdala's current operational status?

Amygdala is currently non-active, having ceased to operate in January 2025.

What technology does Amygdala utilize?

Amygdala's technology utilizes advanced deep learning algorithms to analyze and interpret brain activity, aiming to provide more accurate and reliable results for mental health treatment.